FISCHER JOST 4
4 · AEON Biopharma, Inc. · Filed May 21, 2025
Insider Transaction Report
Form 4
FISCHER JOST
Director
Transactions
- Purchase
Class A Common Stock
2025-05-19$0.50/sh+50,000$24,940→ 146,785 total - Purchase
Class A Common Stock
2025-05-20$0.51/sh+60,000$30,360→ 206,785 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades in prices ranging from $0.4844 to $0.51, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.50 to $0.5132, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.